When the Deliverable Acceptance Email Is Your Revenue Trigger
For biotech and life sciences consulting, revenue turns on documented client acceptance of each milestone deliverable, so the acceptance record matters more than whether you pick FloQast or BlackLine. Acceptance often lives as a one-line email in a project lead's inbox, and pass-through lab and CRO costs billed at cost add a second reconciliation.
Vendors Covered in this Article
Disclosure: We may earn a commission if you buy through some links on this page. It doesn't change what we recommend.
Why must the acceptance record leave the inbox?
A deliverable isn't earned revenue until the client actually accepts it, and that acceptance is frequently just a reply email a project lead never forwards to accounting. Build a standing habit of logging every acceptance, date, deliverable, and who confirmed it, in a shared record the close process actually checks, rather than trusting that someone will remember to mention it before the books close.
Say a project lead replies to a client's acceptance email but forgets to log it, and the deliverable sits, fully accepted, unrecognized in the books for a full extra cycle. Revenue that should have posted in month one instead lands in month two, which understates one period and overstates the next in a way that makes trend reporting to investors or a board genuinely misleading, not just imprecise.
A simple acceptance log records:
- The deliverable accepted, such as a protocol, a data package or a regulatory submission draft.
- The date the client accepted it, which is the trigger for recognizing the revenue.
- The name of the person at the client who confirmed acceptance.
- The pass-through lab or CRO costs tied to that milestone, kept on a separate line from consulting fees.
Pass-Through Lab and CRO Costs Need Their Own Line
Costs billed through to the client at cost for contract research organization work or lab analysis shouldn't sit in the same bucket as your own consulting fee revenue. Blending the two makes margin on the actual advisory work look different than it really is, sometimes inflated by a large pass-through invoice, sometimes diluted by one, depending on timing.
Say a firm blends a $40,000 CRO pass-through invoice into the same revenue line as its own $25,000 consulting fee for that milestone, showing $65,000 in top-line revenue for a project that actually generated $25,000 of margin. Separating the two lines keeps the firm's real earned revenue visible to anyone reviewing the numbers without having to mentally subtract pass-through costs every time.
Why the Documentation Trail Matters More Than Speed Here
A biotech client often folds your deliverable into their own audited financials, grant reporting, or an eventual due diligence process, which means your acceptance record may get scrutinized by someone outside your firm entirely. A reviewer who can trace every recognized dollar back to a specific accepted deliverable, with a name and date attached, is worth more here than a close that finishes two days faster but leaves that trail thin.
A reviewer preparing for that kind of external scrutiny wants to see the acceptance date, the deliverable description, and the person who confirmed it, all matching what the invoice and the revenue entry say, without having to email three people to piece the story together. Building that habit into the regular monthly close, rather than assembling it retroactively when a due diligence request lands, is what actually saves time when the request eventually comes.
FloQast Fits a Firm With a Manageable Study Count
A consultancy running a handful of concurrent studies, where project leads reliably report acceptance on a predictable schedule, does well on FloQast. The checklist model turns milestone confirmation and pass-through cost tie-out into standing monthly tasks without demanding a heavy setup from a firm whose finance function is often lean.
BlackLine Earns Its Keep at Higher CRO Volume
A firm running many concurrent studies with multiple CROs and labs, each generating its own pass-through invoices on its own timeline, benefits from BlackLine's stronger matching once that volume outgrows what a single reviewer can check by hand each month without missing something.
A Mistake That Shows Up at Contract Renewal
Milestone contracts get renegotiated mid-study more often in this field than most, a deliverable gets redefined, split into two, or combined with another as the science evolves. When that happens, update the revenue recognition schedule the same week, not at the next scheduled close, since continuing to recognize revenue against an outdated deliverable list is one of the quicker ways to overstate a month.
What to Ask a New Project Lead About Close Discipline
A scientist promoted into a project lead role rarely arrives with a finance background, and the habit of logging deliverable acceptance the same day it happens has to be taught explicitly, not assumed. Pair the instruction with one concrete example, a real milestone walked through from client acceptance to recognized revenue, rather than a general policy memo, since a specific example is what a new project lead can actually compare their own work against.
A Question Worth Asking Before Choosing Either Platform
Ask how many of your active studies currently have a deliverable sitting in someone's inbox, accepted but not yet logged anywhere accounting can see, right now, today. A firm that can't answer that question quickly has a documentation gap the platform choice won't fix on its own, since neither FloQast nor BlackLine can log an acceptance nobody told them about.
What Good Looks Like
A well-run life sciences consulting close ties every recognized milestone to a documented acceptance record and keeps pass-through lab and CRO costs on their own reconciliation line, separate from consulting fee revenue.
Building The Capability (5-Stage Skill Ladder)
How to Get Started
Disclosure: We may earn a commission if you buy through some links on this page. It doesn't change what we recommend.
Lab and CRO invoices are easier to route for approval and tie to the right study when payments run through one system instead of a shared inbox.
Firms that bring in independent scientific consultants for specialized study work need those 1099 filings handled correctly alongside ordinary vendor bills.
A dedicated sub-account for pass-through lab and CRO funds keeps that cash visibly separate from consulting fee revenue at a glance.
Frequently Asked Questions
Who should own confirming milestone acceptance, the project lead or accounting?
The project lead should confirm the deliverable was accepted, since they have the direct client relationship, but accounting should own logging it into the record the close actually reviews. Leaving it solely in email threads is how acceptances get missed at close.
How do we handle a pass-through CRO invoice that arrives after we've already recognized the milestone?
Accrue an estimate for the pass-through cost based on the CRO's contract terms if it's known but unbilled, then true it up when the actual invoice lands. Waiting for the invoice before recording any cost overstates your margin on that milestone in the meantime.
Does a small firm need BlackLine for a handful of active studies?
Usually not. At that scale, FloQast's checklist approach covers milestone tracking and pass-through review without the setup BlackLine asks for. Revisit the question once concurrent study count or CRO relationships grow meaningfully.
About the numbers
This guide doesn't quote a sourced benchmark. Figures in it are estimates or general guidance, so check them against your own numbers.
Related Guides
Grant Accounting Rules Before Comparing Audit Tools
How life sciences and biotech consulting firms should handle grant and milestone revenue before comparing FloQast and AuditBoard for controls.
When a Biotech Consulting Client Pays You in Warrants
Client warrants, milestone payments, and spinout entities all complicate a life sciences consulting firm's 409A. Here's how to think it through.
BILL vs Tipalti for Life Sciences and Biotech Consulting Firms
Life sciences and biotech consulting firms manage lab and CRO vendors and grant-funded costs. Here's how BILL and Tipalti compare for that work.
A Biotech Consultancy's Worksheet for Its Own Cap Table
A worksheet for life sciences and biotech consulting firms setting up equity for senior scientific staff, and where Pulley or Carta fits each line.
Cube vs Mosaic for Life Sciences Consulting: Grant and Fee Revenue
How Cube, Mosaic, and Jirav model grant-funded milestones, PhD-level billable rates, and lab overhead allocation for life sciences and biotech consulting firms.
When Lab Testing Revenue Needs Its Own Tax Answer
Scientific consulting advice is usually exempt, but lab testing and analysis services are taxable in a number of states. Here is how to tell the two apart.